Assigning matrix metalloproteinase roles in ischaemic cardiac remodelling

Research output: Contribution to journalReview article

13 Citations (Scopus)

Abstract

Matrix metalloproteinases (MMPs) and their endogenous inhibitors have been studied in the myocardium for the past 2 decades. An incomplete knowledge base and experimental design issues with inhibitors have hampered attempts at translation, but clinical interest remains high because of strong associations between MMPs and outcomes after myocardial infarction (MI) as well as mechanistic studies showing MMP involvement at multiple stages of the MI wound-healing process. This Review focuses on how our understanding of MMPs has evolved from a one-dimensional early focus on measuring MMP activity, monitoring MMP:inhibitor ratios, and evaluating one MMP-substrate pair to the current use of systems biology approaches to integrate the whole MMP repertoire of roles in the left ventricular response to MI. MMP9 is used as an example MMP to explain these concepts and to provide a template for examining MMPs as mechanistic mediators of cardiac remodelling.

Original languageEnglish (US)
Pages (from-to)471-479
Number of pages9
JournalNature Reviews Cardiology
Volume15
Issue number8
DOIs
StatePublished - Aug 1 2018

Fingerprint

Matrix Metalloproteinases
Myocardial Infarction
Matrix Metalloproteinase Inhibitors
Systems Biology
Knowledge Bases
Wound Healing
Myocardium
Research Design

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Assigning matrix metalloproteinase roles in ischaemic cardiac remodelling. / Lindsey, Merry L.

In: Nature Reviews Cardiology, Vol. 15, No. 8, 01.08.2018, p. 471-479.

Research output: Contribution to journalReview article

@article{5c8564b9960347eabe2b2a9427b5a317,
title = "Assigning matrix metalloproteinase roles in ischaemic cardiac remodelling",
abstract = "Matrix metalloproteinases (MMPs) and their endogenous inhibitors have been studied in the myocardium for the past 2 decades. An incomplete knowledge base and experimental design issues with inhibitors have hampered attempts at translation, but clinical interest remains high because of strong associations between MMPs and outcomes after myocardial infarction (MI) as well as mechanistic studies showing MMP involvement at multiple stages of the MI wound-healing process. This Review focuses on how our understanding of MMPs has evolved from a one-dimensional early focus on measuring MMP activity, monitoring MMP:inhibitor ratios, and evaluating one MMP-substrate pair to the current use of systems biology approaches to integrate the whole MMP repertoire of roles in the left ventricular response to MI. MMP9 is used as an example MMP to explain these concepts and to provide a template for examining MMPs as mechanistic mediators of cardiac remodelling.",
author = "Lindsey, {Merry L.}",
year = "2018",
month = "8",
day = "1",
doi = "10.1038/s41569-018-0022-z",
language = "English (US)",
volume = "15",
pages = "471--479",
journal = "Nature Reviews Cardiology",
issn = "1759-5002",
publisher = "Nature Publishing Group",
number = "8",

}

TY - JOUR

T1 - Assigning matrix metalloproteinase roles in ischaemic cardiac remodelling

AU - Lindsey, Merry L.

PY - 2018/8/1

Y1 - 2018/8/1

N2 - Matrix metalloproteinases (MMPs) and their endogenous inhibitors have been studied in the myocardium for the past 2 decades. An incomplete knowledge base and experimental design issues with inhibitors have hampered attempts at translation, but clinical interest remains high because of strong associations between MMPs and outcomes after myocardial infarction (MI) as well as mechanistic studies showing MMP involvement at multiple stages of the MI wound-healing process. This Review focuses on how our understanding of MMPs has evolved from a one-dimensional early focus on measuring MMP activity, monitoring MMP:inhibitor ratios, and evaluating one MMP-substrate pair to the current use of systems biology approaches to integrate the whole MMP repertoire of roles in the left ventricular response to MI. MMP9 is used as an example MMP to explain these concepts and to provide a template for examining MMPs as mechanistic mediators of cardiac remodelling.

AB - Matrix metalloproteinases (MMPs) and their endogenous inhibitors have been studied in the myocardium for the past 2 decades. An incomplete knowledge base and experimental design issues with inhibitors have hampered attempts at translation, but clinical interest remains high because of strong associations between MMPs and outcomes after myocardial infarction (MI) as well as mechanistic studies showing MMP involvement at multiple stages of the MI wound-healing process. This Review focuses on how our understanding of MMPs has evolved from a one-dimensional early focus on measuring MMP activity, monitoring MMP:inhibitor ratios, and evaluating one MMP-substrate pair to the current use of systems biology approaches to integrate the whole MMP repertoire of roles in the left ventricular response to MI. MMP9 is used as an example MMP to explain these concepts and to provide a template for examining MMPs as mechanistic mediators of cardiac remodelling.

UR - http://www.scopus.com/inward/record.url?scp=85046741941&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046741941&partnerID=8YFLogxK

U2 - 10.1038/s41569-018-0022-z

DO - 10.1038/s41569-018-0022-z

M3 - Review article

C2 - 29752454

AN - SCOPUS:85046741941

VL - 15

SP - 471

EP - 479

JO - Nature Reviews Cardiology

JF - Nature Reviews Cardiology

SN - 1759-5002

IS - 8

ER -